Susan C. Stansfield, Ph.D. has been named executive vice president, Clinical Development at Premier Research Group. Dr. Stansfield will have global responsibility for leading and developing the company’s clinical trial management services provided to the biopharmaceutical industry.

“Sue’s deep industry knowledge and proven leadership skills will be pivotal in enhancing the value our clinical development organization provides to our customers,” commented Dr. Ludo Reynders, PRG’s chief executive officer. “As demand for our services continues to grow, Sue will focus on ensuring that scientific and operational excellence remains at the heart of our organization. Sue’s exceptional skills and experience in the areas of program and project management will be invaluable in providing superior and appropriate services to our customers in today’s rapidly changing drug development world.”

Dr. Stansfield has more than 25 years of experience in the pharmaceutical and contract research industries. She has worked at three of the leading clinical service organizations (PRA, PPD and Quintiles), taking increasingly responsible leadership roles in project management and clinical operations. This included responsibility for 2,000 staff located in 50 countries.